FIELD: medicine.
SUBSTANCE: patient's blood plasma is examined for the contents of matrix metalloproteinase-7 (MMP-7). If the MMP value is 7.0 ng/ml or higher, a mucoviscidosis severity level is considered to be severe, while the value falling within the range 5.0-7.0 ng/ml shows a moderate degree, and the value ranging 2.0-5.0 ng/ml - a slight mucoviscidosis degree.
EFFECT: use of the method allows higher diagnostic accuracy for the intensity of pulmonary fibrosis in children with mucoviscidosis.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PROGRESSION OF CYSTIC FIBROSIS DIAGNOSED BY NEONATAL SCREENING | 2013 |
|
RU2523888C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF INFLAMMATION AND SQUAMOUS CELL CARCINOMA OF THE MUCOUS MEMBRANE OF THE TONGUE BY THE CONTENT OF BIOMARKERS IN THE ORAL FLUID OF THE PATIENT | 2022 |
|
RU2786804C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BUCCAL MUCOSA FORMATION BY THE CONTENT OF BIOMARKERS IN THE PATIENT'S ORAL FLUID | 2022 |
|
RU2782093C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF THE FORMATION OF THE MUCOUS MEMBRANE OF THE LIP ACCORDING TO THE CONTENT OF BIOMARKERS IN THE ORAL FLUID OF THE PATIENT | 2022 |
|
RU2782092C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF OCCUPATIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PERSONS WORKING UNDER CONDITIONS OF EXPOSURE TO INDUSTRIAL AEROSOLS CONTAINING NANOPARTICLES WITH SILICON | 2023 |
|
RU2803246C1 |
| QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR PAROTID GLAND GROWTHS SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS | 2013 |
|
RU2527676C1 |
| METHOD OF QUALITATIVE DIFFERENTIAL EXPRESS-DIAGNOSTICS OF LIP MUCOSA NEOPLASMS BY CONTENT OF BIOMARKERS IN PATIENT'S ORAL FLUID | 2013 |
|
RU2535076C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
| DIAGNOSTIC TECHNIQUE FOR DISTURBED THROMBOCYTE AGGREGATION ACCOMPANYING MUCOVISCIDOSIS IN CHILDREN | 2013 |
|
RU2533287C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
